Transcription in eukaryotes is a tightly regulated, multistep process. Gene-specific transcriptional activators, several different co-activators and general transcription factors are necessary to access specific loci to allow precise initiation of RNA polymerase II transcription. As the dense chromatin folding of the genome does not allow the access of these sites by the huge multiprotein transcription machinery, remodelling is required to loosen up the chromatin structure for successful transcription initiation. In the present review, we summarize the recent evolution of our understanding of the function of two histone acetyl transferases (ATs) from metazoan organisms: GCN5 and PCAF. Their overall structure and the multiprotein complexes in which they are carrying out their activities are discussed. Metazoan GCN5 and PCAF are subunits of at least two types of multiprotein complexes, one having a molecular weight of 2 MDa (SPT3-TAF9-GCN5 acetyl transferase/TATA binding protein (TBP)-free-TAF complex/PCAF complexes) and a second type with about a size of 700 kDa (ATAC complex). These complexes possess global histone acetylation activity and locus-specific co-activator functions together with AT activity on non-histone substrates. Thus, their biological functions cover a wide range of tasks and render them indispensable for the normal function of cells. That deregulation of the global and/or specific AT activities of these complexes leads to the cancerous transformation of the cells highlights their importance in cellular processes. The possible effects of GCN5 and PCAF in tumorigenesis are also discussed.
Introduction
Transcription in eukaryotes is a tightly regulated, multistep process. Gene-specific transcriptional activators, several different cofactors and general transcription factors are necessary to access specific loci to allow precise initiation of RNA polymerase II (Pol II) transcription. One of the most appealing questions in eukaryotic transcription is how activators can transmit their signals to the general transcription machinery to stimulate transcription in the context of a chromatin environment. Post-translational modifications of nucleosomal histones have been correlated with the involvement of the chromatin in transcription activation or repression (Kingston et al., 1996; Eberharter and Becker, 2002) . One of the most extensively studied modifications is the acetylation of the highly conserved N-terminal histone tails. The basic repeating unit of chromatin is the nucleosome consisting of 146 bp of DNA wrapped around a histone octamer containing two copies of each histones H2A, H2B, H3 and H4. The steady-state acetylation level of histone proteins is accomplished by the action of histone acetyltransferases (HATs) and histone deacetylases (HDACs) (Cheung et al., 2000; Narlikar et al., 2002) . The modifications carried out by the different HATs take place on the e-amino group of lysine (K) residues using acetyl coenzyme A as a coenzyme. Acetylation affects higher-order folding of chromatin fibres, loosening of the contacts between the DNA and the nucleosomes and/or histone-non-histone protein interactions (Tse et al., 1998; Carruthers and Hansen, 2000; Wolffe and Hansen, 2001; Fischle et al., 2003; Shogren-Knaak et al., 2006) . Thus, HATs are thought to increase the decompaction of chromatin, which in turn may increase the accessibility of factors that promote transcription (Krajewski and Becker, 1998; Akhtar and Becker, 2000; Sterner and Berger, 2000; Shogren-Knaak et al., 2006) . It is noteworthy that in vitro hyperacetylation of histone tails seems to weaken only histone tail-DNA binding (Mutskov et al., 1998) . Thus, histone tails do not seem to function as simple inhibitors of transcription factor access, but rather their dynamic acetylation state is important in enhancing factor access and transcription regulation.
The first histone-specific HAT, p55, was isolated from Tetrahymena and shown to be the homologue of the yeast GCN5 (general control nonderepressible 5) putative transcriptional adaptator and, thus, was the first enzyme to link histone acetylation and transcriptional activation (Brownell and Allis, 1996) . Since then, many HATs have been identified. The HATs are divided into five families, including the GCN5-related N-acetyltransferases (GNATs); the MYST (for 'MOZ, Ybf2/Sas3, Sas2 and Tip60')-related HATs; p300/CREBbinding protein (CBP) HATs; the general transcription factor HATs including the TFIID subunit TBP-associated factor-1 (TAF1); and the nuclear hormone-related HATs SRC1 and ACTR (SRC3) (Roth et al., 2001; Carrozza et al., 2003) . In addition, a large number of studies have provided a direct molecular link between histone acetylation and transcriptional activation (reviewed in Kuo and Allis, 1998; Verdone et al., 2005) . In these reports, it has been shown that several previously identified co-activators/adapters of transcription possess intrinsic HAT activity. Interestingly, many of these chromatin-modifying activities have been found within large multiprotein complexes. It also became clear that HAT activity containing complexes can also function as simple acetyl transferases (ATs) and catalyse the acetylation of nonhistone substrates leading to changes in their activity or stability (Sterner and Berger, 2000; Yang, 2004a) .
Since their identification, many reviews have been written on the structure, role and function of different HATs and HAT-containing complexes (Brown et al., 2000; Sterner and Berger, 2000; Carrozza et al., 2003; Yang, 2004b ) and see the review in this issue on yeast SAGA complex (Baker and Grant, 2007) . Thus, here we will focus only on the findings concerning the metazoan GCN5-and p300/CBP-associated factor (PCAF)-containing complexes.
The structural organization of GCN5 and PCAF proteins and their functions Metazoan GCN5 homologues are similar, but differ from the yeast enzyme because they possess an N-terminal extension Yang et al., 1996; Smith et al., 1998; Xu et al., 1998; Figure 1) . While most of the metazoan genomes code for one GCN5 type factor, vertebrates have a second gene encoding PCAF (p300/CBP-associated factor), which is about 73% identical to GCN5 (Yang et al., 1996;  Figure 1 ). All the known metazoan GCN5 homologues can be divided in two parts: the N-terminal half of the molecule that seems to be metazoan specific, and the C-terminal half, which is highly homologous to the shorter yeast protein (Figure 1 ). The N-terminal half contains the so-called PCAF homology domain, and the C-terminal half contains two other conserved domains: the AT domain and the bromodomain (Sterner and Berger, 2000) and references therein; Figure 1 ). The high-resolution crystal structure of the AT domain of Tetrahymena GCN5 (tGCN5) bound to its physiologically relevant ligands, coenzyme A (CoA) and a histone H3 peptide was determined . This study together with that of the PCAF AT domain (Clements et al., 1999) revealed that the central core region of these domains mediate acetyl CoA binding and catalysis, while the N-and C-terminal regions of the AT domains contain a related scaffold that seem to mediate histone substrate specificity (Marmorstein, 2001) .
Proteins containing AT domains from the GNAT family constitute one of the largest enzyme superfamilies with over 10 000 representatives from all kingdoms of life. In spite of very modest degrees of overall primary sequence homology, the basic structure of the GNAT fold is extraordinarily conserved (Vetting et al., 2005) . There are large numbers of known substrates for the GCN5 and PCAF ATs (see also below), out of which histones and nucleosomes are considered to be their major targets (for a review see Yang, 2004a) . Among Figure 1 The overall structure of the GCN5 and PCAF enzymes in vertebrates, Drosophila and yeast. Schematic representation and domain organization of the GCN5 and PCAF proteins from human (hs; Homo sapiens), chicken (gg; Gallus gallus), zebrafish (dr; Danio rerio), pufferfish (tn; Tetraodon nigroviridis), Drosophila melanogaster (dm) and yeast (sc; Saccharomyces cerevisiae) are shown. The PCAF homology domain (PCAF-HD) is shown in grey, the AT domain is shown in black and the bromo domain (Bromo) is shaded. The recently described ubiquitin E3 ligase domain (E3) of PCAF (Linares et al., 2007) is also indicated. The numbers over the boxes indicate amino-acid positions. The identity between the different factors is indicated in % on the right of the horizontal lines, representing the pair wise comparisons. AT, acetyl transferase.
Metazoan GCN5-and PCAF-containing complexes Z Nagy and L Tora free histones, recombinant GCN5 and PCAF have a preference for K14 on histone H3, while they also acetylate K8 and K16 on histone H4, albeit to a lesser extent (Kuo et al., 1996; Grant et al., 1999; Schiltz et al., 1999) . In yeast, histone H3 K36 is also acetylated in a GCN5-dependent manner (Morris et al., 2006) ; however, it remains to be studied whether GCN5 or PCAF carry out H3 K36 acetylation in metazoans. Importantly, these enzymes, when incorporated into multiprotein complexes and tested on nucleosomes, often change their substrate specificity (see below). The bromodomain is an approximately 110-aminoacid module with roles suggested in many different chromatin related and independent functions. Bromodomains are found in many known nuclear HATs that promote transcription-related acetylation of histones on specific lysine residues, but are absent from cytoplasmic HATs. The most commonly accepted view is that bromodomains recognize acetylated histone tails and thus participate in acetylation-dependent chromatin remodelling (Hassan et al., 2001b; Zeng and Zhou, 2002; de la Cruz et al., 2005; Carey et al., 2006) . Structural studies of both yGcn5 and hPCAF bromodomains in complex with histone tail peptides showed that GCN5 bromodomain binds to histone H4 acetylated at K16 (Hudson et al., 2000; Owen et al., 2000) , while PCAF bromodomain seems to recognize histone H4 tail acetylated on K8 and also to H3 tail acetylated on K14 (Dhalluin et al., 1999) . The fact that these HATs were often shown to bind through their bromodomains to the same acetylated residues on histones, which they are supposed to acetylate themselves, raises the question: how would this work? One possibility is that on the chromatin template GCN5-or PCAF-containing complex would first acetylate a given site without binding to it; subsequently, a second complex will read and bind this acetylated mark and then acetylate another site. The second site may even be on another histone tail, which would fit with the extended specificity of the corresponding complexes (see below). In this respect, it is interesting to note that in the yeast SPT-ADA-GCN5 AT (SAGA) complex there are two bromodomain containing proteins (GCN5 and Spt7) of which only the GCN5 bromodomain is required for in vitro anchoring of the complex to the acetylated chromatin (Hassan et al., 2002; Hassan et al., 2007) . However, in the homologous human complex only GCN5 contains a bromodomain and hSPT7L does not possess such a region (Soutoglou et al., 2005; Demeny et al., 2007) . Surprisingly, in vivo analysis of GCN5 mutant proteins revealed that while the PCAF homology and the HAT catalytic domains are required for the function of the Drosophila protein, its bromodomain appeared to be dispensable (Carre et al., 2005) . This suggests that the bromodomain of dGCN5 may not be the only domain responsible for directing or anchoring the GCN5-containing complexes to their sites of action.
Recently, it was also shown that PCAF could function as a ubiquitin E3 ligase for Hdm2, an oncoprotein that promotes p53 degradation, and thus play a role in regulating cellular p53 levels (Linares et al., 2007) . The potential E3 ligase activity of PCAF is within the socalled PCAF homology domain (Figure 1 ). Thus, interestingly, PCAF is not only a HAT, but is also an ubiquitination factor with intrinsic E3 ligase activity, which underlines the functional connections between cellular acetylation and ubiquitination machineries (Caron et al., 2005) . Whether GCN5 also harbours an E3 ligase activity in its relatively conserved PCAFhomology domain (Figure 1) , and the specificity of the E3 ligase activities of PCAF and possibly GCN5, remains to be determined.
Two distinct GCN5-containing complexes exist in metazoans and they seem to have a highly conserved subunit composition
The 2 MDa GCN5-containing STAGA/TFTC-type complexes GCN5 and PCAF, as most of the native nuclear HATs, exist as components of large multisubunit complexes. In metazoans the first GCN5-containing complexes were purified from human cells. Following their identification, the characterization of the subunit composition of the human complexes indicated that they are similar to the 2 MDa class yeast SAGA complex (Table 1; for review see Baker and Grant, 2007) . These human complexes were purified using either double immunoprecipitations with antibodies recognizing endogenous factors, such as the TBP-free-TAF complex (TFTC; Wieczorek et al., 1998; Brand et al., 1999b) , or overexpressing a putative subunit with a tag and then using the tag to purify the complexes, that is the PCAF and GCN5 complexes , and the SPT3-TAF9-GCN5 acetyltransferase (STAGA) complex (Martinez et al., 1998) . These complexes all contain either GCN5 or PCAF as catalytic HAT subunit (Table 1) . In addition, all of them contain a set of TBP-associated factors (TAFs) and several human homologues of proteins that were earlier identified in yeast screens as proteins necessary for either correct transcription initiation site selection by Pol II (the TBP group of Spt proteins (Winston and Sudarsanam, 1998)) or for activated transcription (the Ada group of proteins; Berger et al., 1992; Pina et al., 1993; Roberts and Winston, 1996 ; see also Table 1 ). These human complexes contain also a 400 kDa protein, TRRAP (TRansactivation/tRansformation domain Associated Protein; also called PAF400) that was originally isolated as a Myc-associated transcription co-activator (McMahon et al., 1998) . A novel proteomic investigation of the yeast SAGA complex has identified three novel SAGA-associated factors (Sgf73, Sgf29 and Sgf11) together with Ubp8, a ubiquitin-specific protease component, which suggested that a second enzymatic activity exists within these complexes (Sanders et al., 2002; Powell et al., 2004) . Recently, it became clear that the vertebrate homologues of some of the novel yeast SAGA factors (ATXN7 and SGF29 in Table 1 ) are also present in either STAGA or TFTC (Helmlinger et al., 2004; Palhan et al., 2005; Kurabe et al., 2007) . While the originally described human TFTC, PCAF/GCN5 and STAGA complexes shared a number of common subunits, they did not seem to be identical, suggesting variations due to their distinct purification protocols or the existence of functional difference between these complexes. Since their original identification, a lot of information has been published on the subunit composition and function of the TFTC and the STAGA complexes (Table 1) (Brand et al., 2001; Martinez et al., 2001; Cavusoglu et al., 2003; Helmlinger et al., 2004; Palhan et al., 2005; Demeny et al., 2007) . Thus, today these 2 MDa GCN5-containing complexes, which can be biochemically isolated from human cells, seem to be very similar. Indeed, originally a series of TAFs (TAF2, TAF4, TAF5 and TAF6) have been described as components of the endogenous TFTC (Wieczorek et al., 1998) . However, now it seems clear that the initial TFTC preparation can be further separated into the GCN5-containing 2 MDa TFTC, which seems to be almost identical to the STAGA complex, and a series of additional TAF-containing complexes (see Table 1 ; Demeny et al., 2007; and our unpublished results) . Concerning the PCAF complex, further analysis will be necessary to compare this complex to the STAGA/ TFTC complexes. The identification of hADA2a as a subunit of the PCAF complex would make this complex different from STAGA and TFTC complexes, in which ADA2a is not present, The factors, described in the different complexes (Grant et al., 1997 (Grant et al., , 1998a Martinez et al., 1998 Martinez et al., , 2001 Wieczorek et al., 1998; Brand et al., 1999b; Eberharter et al., 1999; Georgieva et al., 2001; Kusch et al., 2003; Muratoglu et al., 2003; Helmlinger et al., 2004; Rodriguez-Navarro et al., 2004; Palhan et al., 2005; Guelman et al., 2006a; Demeny et al., 2007; Kurabe et al., 2007) , are represented on a horizontal line as homologues from different species. Different names on a horizontal line mean that these homologues are known under different names in different species. The novel TAF nomenclature has been used (Tora, 2002) . '?' means that cDNAs encoding homologue factors to the yeast proteins in the given organism have been identified, but the presence of the factor in the corresponding complex has not yet been demonstrated. '-' means that in the given complex the corresponding factor is absent. Factors shown with ' # ' have been recently identified in TFTC by mass spectrometry (our unpublished results). Factors in TFTC shown with '*' copurify with TFTC, but seem to be present in a separate complex (Demeny et al., 2007) and our unpublished results). STAFs in green were positioned as homologues of the yeast proteins, when cDNAs encoding putative human proteins with approximately the STAF size were found. but replaced by the homologous factor hADA2b (Table 1) .
In Drosophila, there is only one gene encoding a GCN5-type protein. Similarly to the human and the yeast 2 MDa GCN5-containing HAT complexes, several laboratories have purified and partially characterized SAGA/TFTC-type complexes from Drosophila cell extracts (Georgieva et al., 2000 (Georgieva et al., , 2001 Kusch et al., 2003; Muratoglu et al., 2003; Guelman et al., 2006b) . At present only the partial polypeptide composition of this Drosophila complex is known (see Table 1 ); however, it strongly resembles the yeast SAGA and the human STAGA/TFTC-type complexes. Note, that E(y)2, the Drosophila homologue of the last identified yeast SAGA subunit (ySus1) was also identified in the fly STAGA/TFTC complex (Georgieva et al., 2001; Rodriguez-Navarro et al., 2004) and Kurshakova et al., submitted). Comparison of these 2 MDa GCN5-containing complexes isolated from yeast, fly and human cells demonstrate that they share a much more conserved subunit composition than originally thought. The high level of homology between the corresponding subunits (Table 1) together with the conserved structure of the 2 MDa complexes (see below and Figure 2 ) strongly suggest that they would fulfil the same function in distinct species.
Similarly to ySAGA, the Drosophila STAGA/TFTC, the human TFTC, PCAF/GCN5 and STAGA HAT complexes preferentially acetylate histone H3 both in free and in a nucleosomal context Grant et al., 1998b; Brand et al., 1999b; Martinez et al., 2001; Kusch et al., 2003; Guelman et al., 2006a) . While free GCN5 acetylates mainly K14 of histone H3 as previously stated, once incorporated into the 2 MDa complexes its specificity changes towards K9, K14, K18, K23 of histone H3, to a lesser extent H2B and H4 (Brand et al., 1999b; Guelman et al., 2006a) . PCAF alone or in complex seems to possess H3 preference on both core histones and nucleosomes ; however, its preference for exact histone H3 lysine residues in the PCAF complex needs to be further investigated. Thus, the subunits of these 2 MDa complexes seem to be indispensable for directing the ATs to specific sites on the chromatin and probably also to other substrates (see below), which they would not acetylate as free enzymes.
The 700 kDa GCN5-containing metazoan ATAC complexes In yeast, in addition to the 2 MDa SAGA, a 700-800 kDa GCN5-containing complex, called ADA, exists. Besides yGCN5, ADA contains yADA2, yADA3 and yAhc1 as well as a series of not yet identified polypeptides with molecular weights of 65, 90, 110, 180 and 250 kDa (Grant et al., 1997; Eberharter et al., 1999) . The yeast ADA and SAGA HAT complexes generate overlapping, yet distinct, patterns of lysine acetylation on histone H3. While the ADA complex acetylates K14 and K18 on histone H3, SAGA acetylates to some extent all four lysines on H3 (Grant et al., 1999) .
Analyses of protein samples purified from either Drosophila or human cell-nuclear extracts separated by size suggested that GCN5-containing complexes also exist in metazoans in at least two distinct populations. One of them has an estimated molecular mass of about 2 MDa while the second possesses a size of about 700 kDa (Forsberg et al., 1997; Kusch et al., 2003; Muratoglu et al., 2003; Demeny et al., 2007) . The purification of the 700 kDa GCN5-containing complex was facilitated by the identification of two Drosophila Ada2 genes encoding ADA2a and ADA2b proteins (Muratoglu et al., 2003) . In fly embryo extracts ADA2a co-fractionates with GCN5 in the 600-700 kDa size range, while ADA2b copurifies with the 2 MDa STA-GA-type complex (Kusch et al., 2003; Muratoglu et al., 2003) . Following this finding, the group of J Workman reported the affinity purification of the Drosophila 700 kDa-HAT complex, called ATAC (ADA two a containing) (Guelman et al., 2006a) . When the dATAC complex was subjected to proteomic analysis, in addition to GCN5, ADA2a and ADA3, two other proteins: ATAC1 and host cell factor (dHCF) were identified and shown to be stable components of the complex, but not that of dSTAGA/TFTC. Note, however, that possibly more subunits will be identified in dATAC, since the estimated molecular mass of the complex (700 kDa) is much higher than the sum of the masses of the already known subunits (450 kDa) (Guelman et al., 2006a) . In vertebrates, there are also observations suggesting the existence of a human GCN5-containing ATAC complex: (i) in vertebrates (and also in plants) two genes Figure 2 The overall three-dimensional structure of the GCN5-containing 2 MDa yeast SAGA and human TFTC complexes is evolutionarily conserved. (a) The low-resolution three-dimensional structure of the yeast SAGA and human TFTC was elucidated via EM methods (Brand et al., 1999a; Wu et al., 2004) . Image reconstruction yielded a three-dimensional model at B30 Å resolution, which revealed that both SAGA and TFTC complexes have an evolutionarily well-conserved structure. Alignment and superposition of the SAGA model (blue) with that of human TFTC (red) is shown and the five modular domains of the complexes as defined by Wu et al. (2004) are indicated with white circles. The theoretical position of GCN5 (or PCAF) in the superposition is indicated. (b) The different subunits of SAGA, which were identified in the distinct domains (Wu et al., 2004) , are summarized.
have been described encoding ADA2a and ADA2b proteins (Stockinger et al., 2001; Barlev et al., 2003; Muratoglu et al., 2003) ; (ii) endogenous GCN5 can be found in fractions having a size of 600-700 kDa (Demeny et al., 2007) , (iii) ADA2b is present in human STAGA/TFTC-type complexes (Vlachonasios et al., 2003; Palhan et al., 2005 ; and our unpublished observation) and (iv) human ADA2a co-immunoprecipitates with either GCN5 or PCAF , suggesting that ADA2a will be in the smaller GCN5-(or PCAF-) containing complex similar to what has been described in flies. Furthermore, the existence of a smaller GCN5-containing complex has been suggested in human cells (Forsberg et al., 1997) . It is too early to say whether there is a functional and/or subunit similarity between the yeast ADA complex and that of the metazoan ATAC-type complexes. Additional subunits of all of these complexes have to be identified and their roles in acetylation, chromatin structure maintenance and/or transcriptional activation have to be compared.
When the HAT activity of the fly dATAC complex was tested on free histones, both histones H3 and H4 were acetylated to a similar level. However, when assayed on nucleosomes, the dATAC complex showed a substrate preference for histone H4 and to a lesser extent for histone H3 (Guelman et al., 2006a) , in good agreement with several in vivo observations (see below). This finding suggests that dSAGA/TFTC-type complexes would show a histone H3 acetylation preference, while dATAC would acetylate histone H4 (see below). Thus, it seems that the subunits of these complexes not only direct the ATs to specific sites on the chromatin, but in addition the different subunit composition of the two HAT complexes change the substrate specificity of the GCN5 AT enzyme. Whether a PCAF-containing ATAC complex also exists in vertebrates has to be determined.
Three-dimensional structure of the 2 MDa GCN5-containing HAT complexes
To understand better the function of the 2 MDa GCN5-containing complexes, their structure and the positions of the subunits were identified. The low-resolution threedimensional structure of both yeast SAGA and human TFTC was elucidated by electron microscopy (EM) (Brand et al., 1999a; Wu et al., 2004) . In these studies, negatively stained SAGA and TFTC particles in various orientations were viewed by EM. Image reconstruction yielded a three-dimensional model at B30 Å resolution, which revealed that both SAGA and TFTC have an elongated shape of 160 Å Â 270 Å in size. Both complexes consist of five modular substructures of 70-100 Å in diameter (called domains) separated by solventaccessible grooves (see Figure 2 ).
An overlay of the yeast SAGA and the human TFTC structures indicated, in good agreement with their similar subunit composition, a high degree of structural conservation in size and shape (Brand et al., 1999a; Wu et al., 2004; Timmers and Tora, 2005) and, thus, it is expected that the metazoan subunits will position to similar domains as described in the yeast complex. The distinct domains of SAGA were revealed by mapping of its subunits by immuno-EM methods (Figure 2 ). Domain I of SAGA contains Tra1 that seems to represent the activator interaction surface. Domains II, III and IV contain several histone fold-containing TAFs and TAF5, which might play an architectural role in these complexes. In domain III the two bromodomaincontaining subunits, GCN5 and Spt7, were detected (Figures 2a and b ). Biochemical and genetic interaction studies suggest that they would colocalize with ADA2 and ADA3, indicating that domain III is not only a central architectural domain, but also harbours the HAT activity. Domain V, of which the structure seems to be more flexible, contains Spt3, Spt20 and probably also Spt8 and defines the TBP interaction module (Sermwittayawong and Tan, 2006) .
At present, less is known about the exact polypeptide composition and the structure of the ATAC-type complexes, which need to be determined in the future.
In vivo roles of GCN5-and PCAF-containing complexes in metazoans
Drosophila GCN5 is an essential protein since Gcn5 mutants fail to undergo metamorphosis and die at the end of the larval period (Carre et al., 2005) . In agreement with its original characterization, Drosophila GCN5 was found in vivo to be involved in acetylation of larval polytene chromosomes at positions K9 and K14 of histone H3, and surprisingly also in acetylation of K5 and K12 of histone H4, which was not predicted from the original biochemical studies (Carre et al., 2005; Ciurciu et al., 2006) and see above). Similar to GCN5, both Drosophila Ada2 genes are essential. Ada2a homozygote mutants are late-larva lethal, while Ada2b mutant animals die later at the end of the prepupal phase (Qi et al., 2004; Pankotai et al., 2005) . Mutations of the Ada2b gene result in a loss of acetylation of residues K9 and K14 on H3, while Ada2a mutations only affect acetylation of K5 and K12 residues on histone H4 when tested on polytene chromosomes (Qi et al., 2004; Pankotai et al., 2005; Ciurciu et al., 2006) . Altogether these observations strongly suggest that dSAGA and dATAC have distinct substrate specificities and biological roles in vivo. The differential histone acetylations carried out by the two complexes seem to determine distinct functions in changing the chromatin structure and also in consequent downstream regulatory events.
The in vivo roles of GCN5 or PCAF were also studied in chicken DT40 cells, where the two alleles of either Gcn5 or Pcaf genes were deleted (Kikuchi et al., 2005) . While the PCAF deficiency did not affect cell growth that of GCN5 caused a delay in growth rate of the DT40 cells. Interestingly, the steady-state level of PCAF, originally being undetectable in DT40 cells, was tremendously increased in GCN5-lacking cells, while the expression of other HAT proteins did not change (Kikuchi et al., 2005) . Similarly, among the HDACs examined, the level of HDAC-4 significantly increased in Gcn5À/À cells, although no such changes for the remaining HDACs were observed. These findings indicated that in GCN5-lacking cells, PCAF and/or HDAC-4 play compensatory roles in chromatin dynamics. In agreement with this observation, in the cells lacking GCN5, but now misexpressing PCAF, acetylation levels of K9 on histone H3 heavily decreased and acetylation of K23 on H3, K8 and K12 on histone H4 also increased, while K14 acetylation on histone H3 stayed constant (Kikuchi et al., 2005) . Moreover, gene expression analyses revealed that the GCN5-deficiency affected the transcription of G 1 /S phase transitionrelated genes and also that of some apoptosis-related ones. These results together indicated that the functions of GCN5 and PCAF are not redundant in a given cell and show that GCN5 has unique functions in regulating either global histone acetylation and/or specificgene expression.
GCN5 is also an essential protein in mouse development as Gcn5À/À mice die during embryogenesis at 10.5 days post coitum (d.p.c.) and they fail to form dorsal mesoderm (Xu et al., 2000) . Loss of the dorsal mesoderm lineages seems to be due to apoptosis in the Gcn5À/À mutants, in agreement with the DT40 cell experiment. Although GCN5 physically interacts with p300 and CBP (Xu et al., 1998) , the phenotypes of mice lacking p300 are substantially different from those lacking GCN5, suggesting that GCN5 functions are unique and are not supplementary to those of p300 and CBP (Yao et al., 1998; Xu et al., 2000) . The different phenotypes indicated that individual HATs are required for specific developmental processes.
In contrast, PcafÀ/À mice develop normally, without any observable phenotype (Xu et al., 2000; Yamauchi et al., 2000) . Importantly, in the viable Pcaf knockout (KO) mice, GCN5 protein levels are drastically elevated in several tissues where PCAF is normally expressed in wild-type mice, suggesting, together with the DT40 results (Kikuchi et al., 2005) , that GCN5 and PCAF can functionally compensate (although only partially) the loss of the other factor. Despite PCAF being identified on the basis of its physical interaction with CBP and p300 (Yang et al., 1996) , the lack of a phenotype of the PcafÀ/À mutant mice demonstrated that PCAF is not absolutely required for p300 or CBP functions. Double mutant animals lacking both PCAF and GCN5 die earlier than the single Gcn5 KO animals, somewhere between days 7.5 and 9.5 d.p.c. (Xu et al., 2000; Yamauchi et al., 2000) . These results suggested also that the functions of GCN5 and PCAF are not completely redundant during mouse embryogenesis.
The role of the GCN5-containing HAT complexes in the global acetylation of chromatin HAT complexes are mostly perceived as co-activator complexes recruited to specific loci on the chromatin to carry out gene-specific regulatory functions. However, many of these complexes also have global chromatin modifying functions that are less well understood. GCN5 also acetylates histones genome-wide, a phenomenon affecting most nucleosomes in yeast (Waterborg, 2000) and referred to as global acetylation (reviewed in Kurdistani and Grunstein, 2003) . This global activity results in a basal state of histone acetylation throughout the genome that varies among loci and over which targeted acetylation superimposes. Targeted chromatin modification occurs in a constant balance of global acetylation by yeast GCN5 and deacetylation by the yRpd3 deacetylase. The latter was not only suggested to reduce basal transcription, but also to allow a rapid return to the initial state of acetylation when targeting is removed (Vogelauer et al., 2000) . In addition, yGCN5-dependent global histone acetylation seems to also affect the targeted activation processes by creating a more accessible chromatin environment in general and/or by facilitating preinitiation complex formation at the core promoters (Imoberdorf et al., 2006) . Recently, the Hinnebush laboratory presented evidence that GCN5 within the ySAGA complex mediates transcriptioncoupled acetylation of nucleosomes in transcribed open reading frames (ORFs) (Govind et al., 2007) . This opens the interesting possibility that global chromatin modifying functions of the GCN5-containing complexes may in fact be attributed to global acetylation on ORFs.
Similar conclusions have been drawn in metazoans. Genetic and biochemical analysis in Drosophila led to the conclusion that both the 700 kDa and the 2 MDa GCN5-containing complexes have multiple roles in the cells. The first would be the deposition of histone H3 and H4 acetylation marks along the entire chromosomes, while the second would be the targeted acetylation of histones at specific loci (Figures 3a and b ; and see also below). A decrease in the global acetylation seems to contribute in Drosophila to structural changes observed in the different mutant chromosomes (Ciurciu et al., 2006) . During global acetylation, dATAC and dSAGA/TFTC HAT complexes seem to have distinct preferences for histones H3 and H4, respectively (Figure 3a) . Furthermore, the equivalent vertebrate complexes also play a role in global chromosome acetylation since total histone preparations from Gcn5-lacking cells show very drastic changes in several differently deposited acetyl marks (Kikuchi et al., 2005) . If such changes occurred only at certain specific gene loci, these changes would not be detectable in total histone preparations. Conversely, increased levels of GCN5 alone can strongly augment global nuclear acetylation, indicating that GCN5 has widespread global effects on chromatin, independent of its recruitment by activators (Knoepfler et al., 2006) . Another recent study also described the role of STAGA/TFTC in global chromatin condensation (Helmlinger et al., 2006a) . Spinocerebellar ataxia type 7 (SCA7) is one of the several neurodegenerative disorders caused by a polyQ expansion, but it is the only one in which the retina is affected. Vertebrate Ataxin7 (ATXN7), a homologue of the yeast Sgf73, is a subunit of the STAGA/TFTC-type complexes (Helmlinger et al., 2004; Palhan et al., 2005) and is encoded by the Atxn7 gene. Studying the effect on polyglutamine (polyQ)-expanded Ataxin 7 (ATXN7) on STAGA/ TFTC function revealed an interesting connection between the function of these complexes and global histone acetylation. Careful examination of photoreceptors, in which polyQ-expanded ATXN7 had been exogenously expressed in mouse retina, indicated a dramatic increase in photoreceptor nuclear volume, probably due to chromatin decondensation (Helmlinger et al., 2006a) . Histone hyperacetylation caused by the aberrant HAT function of the polyQ-containing STAGA/TFTC complex was suggested to account for the global chromatin decondensation (Helmlinger et al., 2006a) . Thus, it seemed that hyperacetylation and a consequent dramatic chromatin decondensation disrupted the normally highly compacted chromatin architecture of the differentiated photoreceptor nuclei. Surprisingly, however, this drastic change in the chromosome architecture led to deregulation of only about 1% of the expressed genes, suggesting that global chromatin acetylation and probably higher order chromatin architecture are not major determinants of gene regulation in this cell type. However, the special chromatin organization in photoreceptors appears to be critical to reach high expression levels of photoreceptor specific genes as they were severely downregulated in mutant mice (Helmlinger et al., 2006b ).
The role of the GCN5-and PCAF-containing complexes as co-activators at specific loci Many metazoan transcription activators and cell-cycle regulatory proteins (that are, nuclear receptor, IRF, IFN, STAT, GAGA, HSF, Smad, Myc and E2F family of proteins) contact directly and recruit GCN5-or PCAF-containing complexes to specific promoters (McMahon et al., 1998; Masumi et al., 1999; Agalioti et al., 2000; Anafi et al., 2000; Flinn et al., 2002; Paulson et al., 2002; Yanagisawa et al., 2002; Liu et al., 2003; Kahata et al., 2004; Lebedeva et al., 2005; Figure 3b ). According to the most accepted model (Carrozza et al., 2003) , these activators would directly contact the TRRAP subunit of the HAT complexes; however, it is also possible that different activators can contact distinct subunits in these 2 MDa assemblies. Preceding histone modifications created by other remodelling complexes may influence further the recruitment. Once targeted, STAGA/TFTC/PCAF complexes acetylate mainly histone H3 in the vicinity of the promoters that in turn is thought to stabilize their binding to these promoter regions. In addition, it seems that the targeted binding of the ATP-dependent chromatin-remodelling complexes, containing subunits with bromodomains, also require GCN5-dependent acetylation (Hassan et al., 2001a; Carrozza et al., 2003) . The fact that nucleosomes are known to be evicted from the close vicinity of active promoters (Barrera and Ren, 2006) suggests that these HAT complexes either play a role in the eviction Figure 3 The distinct GCN5-and PCAF-containing complexes possess global histone acetylation activity and locus-specific coactivator functions, together with AT activity on non-histone substrates. (a) Global acetylation. STAGA/TFTC, PCAF and/or ATAC complexes seem to contribute to structural integrity of the chromosomes. Alternatively, global chromatin modifying functions of the GCN5-containing complexes may be attributed to global acetylation on ORFs (Govind et al., 2007) . During global acetylation the ATAC and STAGA/TFTC HAT complexes seem to have distinct preferences for histones H3 or H4, respectively on the different nucleosomes (orange ovals). Highly packed chromatin fibres are represented. (b) The role of the GCN5-and PCAFcontaining complexes as co-activators at specific genes. The model describes the activation process of an eukaryotic gene in the context of chromatin. Once a specific activator (Act-X or -Y) has bound to its binding site or enhancer region (grey box) chromatin-modifying HAT complexes (STAGA/TFTC/PCAF-type, upper panel; or ATAC-type, lower panel) and ATP-dependent chromatin-remodelling complexes (REM) are recruited to the vicinity of the core promoter (purple box). Nucleosomes are acetylated, ATP-dependent chromatin-remodelling complexes are binding to the acetylated histone tails (short red lines) and nucleosomes are mobilized due to these activities (short arrows). Nucleosomes covering the core promoter get evicted and thus, TFIID and other general transcription factors including Pol II can bind to the core promoter region and transcription will start from the given gene (black box). Complexes participating in histone H2B mono-ubiquitination, histone H3 K4 tri-methylation and the deubiquitination activity of the STAGA/TFTC complex are not depicted in this scheme for simplicity. (c) GCN5-and PCAF-containing complexes regulate transcription by directly acetylating transcription factors. The GCN5-or PCAF-dependent acetylation (short red lines) on these nuclear factors can have positive and negative effects on transcription regulation (see text). '?' indicates that in the majority of the documented cases the AT activity and the specificity of the corresponding GCN5-or PCAF-containing complexes was not yet tested. ATAC, ADA two a containing; STAGA, SPT3-TAF9-GCN5 acetyltransferase; TFTC, TBP-free-TAF complex.
process or that they bind to nucleosomes, which stay stably bound further around the promoter region (Figure 3b) . Acetylation of histone H3, and probably also certain histone H4 residues, is supposed to increase the histone H2B monoubiquitination at promoters by hUbcH6, hRNF20/RNF40 and the PAF complexes (Zhu et al., 2005) , which via an unknown mechanism would then also increase histone H3 K4 and K79 tri-methylation carried out by the MLL complex (Shilatifard, 2006) . However, at present, it is not well understood how the subsequent deubiqutination of H2B by the deububiquitinase subunit of the metazoan 2 MDa type GCN5 complexes participates in this sequence of events leading to gene-specific activation. Moreover, the exact mechanism by which the metazoan ATAC complexes function in promoter-specific histone modifications and thus gene activation remains to be further studied (Figure 3b ).
GCN5-and PCAF-containing complexes regulate transcription by directly acetylating transcription factors
In addition to their global and gene-specific HAT activities, the GCN5 and PCAF enzymes have been shown to acetylate numerous transcription factors directly (see Bannister and Miska, 2000; Sterner and Berger, 2000; Yang, 2004a; Glozak et al., 2005 and references therein) (Figure 3c ). By modifying the activity of either basal or gene-specific transcription factors, these ATs exert a third function that seems to be independent of histone acetylation. As the number of transcription factors known to be regulated through acetylation/deacetylation increases, the role of acetylation in gene regulation seems to be as important as phosphorylation (Kouzarides, 2000) . Several reviews have been recently written on the role of GNATs in the regulation of transcription through the acetylation of a large variety of factors (Bannister and Miska, 2000; Sterner and Berger, 2000; Prives and Manley, 2001; Yang, 2004a) , thus here we will only briefly summarize some of these findings. The effects of GCN5 and PCAF on the different non-histone chromatin proteins, chromatin remodellers, sequencespecific transcriptional activators, nuclear receptor cofactors and general transcription factors can be divided in two main groups depending on their output on gene regulation: positive or negative effects. The positive effects of GCN5-or PCAF-dependent acetylation can be stimulation of nuclear localization and/or inhibition of nuclear export of a given factor; stabilization or enhanced DNA binding and consequent stimulation of transcription activation by a given factor; and increased co-activator association. The described negative effects are promotion of nuclear export of a nuclear transcription factor; reduction or inhibition of DNA binding of a given factor; and inhibition of transcription; relocalization of a given cofactor from promoter regions to nuclear foci (Bannister and Miska, 2000; Sterner and Berger, 2000; Yang, 2004a; Lerin et al., 2006) . It should be noted that acetylation is only one type of post-translational modification taking place on these transcription factors. However, they are also subjects of various types of other modifications and the sum of all these modifications determines their effect on the function of the given factor. Interestingly, most of the studies addressed only the role of PCAF as an AT on non-histone targets, while only few examples can be found for GCN5 in this process. Furthermore, in most of the described studies the action of PCAF or GCN5 was investigated as if they would exist in the cell as individual proteins. As GCN5 and PCAF are subunits of either the ATAC-or the STAGA/TFTC/PCAF-type complexes, and thus in the cells they do not seem to exist individually, many of the described transcription factor acetylation and ubiquitination studies would need further verification. Future studies will be needed to understand whether the corresponding GCN5-or PCAF-containing multiprotein complexes carry out the AT and the potential E3 ligase reactions on all of the identified factors in vivo. This is even more important since we know that the different subunits of the distinct HAT complexes can change the substrate specificity of the GCN5 or PCAF enzymes.
The 2 MDa GNAT complexes link transcription and DNA single-strand break repair
The hSAP130 protein, known to be a subunit of the U2 snRNP complex functioning in mRNA splicing (Das et al., 1999) , has been identified both in human TFTC and STAGA complexes (Brand et al., 2001; Martinez et al., 2001) . SAP130 is a member of a protein family having role in DNA repair processes. In line with this, TFTC has been shown to possess higher affinity to ultraviolet (UV)-irradiated DNA and enhanced acetylation activity on nucleosomes formed on irradiated DNA (Brand et al., 2001) . SAP130 was shown to be a substoichiometric subunit of the STAGA complex and a STAGA subfraction lacking SAP130 bound also preferentially UV-irradiated DNA in a dose-dependent manner. In addition to SAP130, DDB1 (UV-damaged DNA-binding protein 1) that is involved in nucleotide excision repair (NER) and the hereditary disease xeroderma pigmentosum -as part of a complex with DDB2 (p48) -was found to be associated with STAGA. The fact that STAGA/TFTC can recognize UVdamaged DNA and subsequently acetylate histones more efficiently than on undamaged templates raises the possibility that the STAGA/TFTC complex plays a role in making the DNA damage accessible for the repair machinery in the context of chromatin.
Importantly, initiation of transcription and NER appear to be closely related as they have been shown to be interdependent processes involving the same transcription factors. It has been demonstrated that the recruitment of certain general transcription factors essential for transcription initiation by the NER machinery to damaged sites is at least partially responsible for the UV-induced inhibition of transcription (Bootsma and Hoeijmakers, 1993; Rockx et al., 2000) . The fact that DNA lesions can sequester STAGA/TFTC may suggest that this factor also contributes to the general reduction of Pol II transcription observed in UV-irradiated human cells. STAGA/TFTC -by binding to UV lesions -may deliver HAT activity to the damaged sites, consequently loosening up the chromatin around these regions and thus facilitating the rapid access of the NER machinery to the UV lesions. This is consistent with the observation that DNA repair synthesis is enhanced on hyperacetylated nucleosomes and also that NER is facilitated by ATP-dependent chromatin-remodelling factors. These remodellers may arrive after or during the acetylation signal is deposited by GCN5 (Ura et al., 2001) . Thus the 2 MDa GNAT complexes link chromatin modifications and DNA repair.
The role of GCN5-and PCAF-containing complexes in oncogenic gene regulation Aberrations in post-translational modifications of histones have been shown to occur in cancer cells at individual promoters (Barsyte-Lovejoy et al., 2006; Jia et al., 2006) . Changes in global levels of histone modifications are also associated with cancer and these changes are predictive of clinical outcome (Seligson et al., 2005) . The mechanistic basis of either the altered expression of AT enzymes or changes in their AT activity due to altered interactions within the corresponding HAT complexes is still not clear. However, there is increasing experimental evidence suggesting the importance of overall perturbation of different AT and HAT activities in cancerogenesis. Because a fine balance between acetylation and deacetylation regulates the cellular function of all the above-mentioned acetylated factors, the smallest change in this balance can lead to serious consequences in the life span of the cell. Some HDAC inhibitors are at the clinical trial step in cancer therapies with promising results (Lin et al., 2006) or already approved, further indicating that in many tumorigenic cells global HAT or AT activities have been seriously deregulated. As HDACs also deacetylate non-histone proteins, the effect of HDAC inhibitors may, at least partially, be the result of inhibiting deacetylation of the above-mentioned transcription factors.
As GCN5-and PCAF-containing complexes are known to function as cofactors for several protooncoproteins; here, we will only summarize some examples of their described roles in the action of these oncogenic factors. The largest subunit of the 2 MDa GNAT complexes, TRRAP is a member of the ataxia telangiectasia mutated (ATM)/phosphotidylinositol 3-kinase-like kinase (PIKK) kinase family, and has been originally isolated as a cofactor of the oncogene c-Myc (McMahon et al., 1998) . The Myc family of oncoproteins (c-Myc, L-Myc and N-Myc) play a role in the pathogenesis of many human neoplastic diseases (Nesbit et al., 1999) . TRRAP interacts with the N-terminal part of Myc after mitogen-mediated activation, and as a consequence, the two proteins become chromatin associated (Frank et al., 2001) . After this step, histone H4 is acetylated at several gene promoters, closely followed by mRNA accumulation in a Myc-dependent manner (Frank et al., 2001) . Recent studies have shown that c-Myc is present on the chromatin in association with TFTC/STAGA/PCAF and other HAT complexes, all containing TRRAP (Flinn et al., 2002; Frank et al., 2003; Liu et al., 2003) . Max is a helix-loop-helix zipper protein that associates with Myc family proteins to form a sequence-specific DNA-binding complex. A recent study showed that the Max/Myc heterodimer could associate with STAGA subunits such as TRRAP, GCN5, TAF5L, TAF9 and SPT3 (Liu et al., 2003) . All of these subunits can be found both in TFTC and STAGA (see Table 1 ), indicating that the 2 MDa GCN5-containing HAT co-activator complex is recruited by Myc to the the Myc-dependent promoters. A naturally occurring truncated form of Myc, which does not interact with purified STAGA complex, shows reduced transcription activation potential and cannot transform primary cells (Spotts et al., 1997) . This result clearly suggests that oncogenic transformation carried out by Myc is not a result of the protein per se, but rather depends on its physical and functional contact with multisubunit GCN5-containing complexes. In good agreement with the observed strong interaction between Myc and the STAGA/TFTC complex, it was described that Myc also influences the global chromatin structure (Knoepfler et al., 2006) . The knockdown of GNC5 following shRNA treatment interferes with Myc-induced global acetylation, providing evidence that GCN5 itself is the global HAT involved. Thus, Myc seems to regulate acetylation levels through both a direct pathway, recruiting HAT complexes to its numerous binding sites, and an indirect one, activating transcription of the Gcn5 gene (Knoepfler et al., 2006) . The E2F family of transcription factors are critical for cell-cycle regulation and any deregulation of the E2F pathways can lead to cancerous changes, as indeed happens in most of the cases reported (Johnson and Degregori, 2006) . PCAF has been described as an AT acetylating E2F1, which leads to an increase in its DNAbinding activity, stability and transactivation (MartinezBalbas et al., 2000; Marzio et al., 2000) . E2F1 and E2F4 interact directly with TRRAP and GCN5, suggesting that E2F family of factors stimulate transcription by recruiting the essential cofactors GCN5 and TRRAP (Lang et al., 2001) , probably as subunits of the endogenous STAGA/TFTC complexes. These results provide a mechanism for E2F-transcription factors to overcome dominant repression of transcription. Note, however, that on certain E2F-regulated gene promoters the STAGA/TFTC-type complexes may synergize with other HAT complexes (that is, TIP60/NuA4) as H4 acetylation mark and TIP60 have been also detected at E2F-responsive genes (Taubert et al., 2004) .
p53 is one of the most extensively studied tumoursuppressor proteins in mammalian organisms. The activation of the protein can lead to cell-cycle arrest or apoptosis depending on the genotoxic agent and the subsequent post-translational modifications occurring on its polypeptide backbone (Bode and Dong, 2004) . The N-terminal activation domains of p53 require GCN5 to regulate gene expression by influencing chromatin modifications . Moreover, antibodies against Drosophila p53 immunoprecipitated dADA2b and dGCN5, but not dADA2a, from nuclear extract suggesting that endogenous dSAGA/ TFTC-type complexes interact with Dmp53 in vivo (Kusch et al., 2003) . Several kinases have been implicated in the phosphorylation of different residues of p53 (Sakaguchi et al., 1998; Appella and Anderson, 2001) , and were shown to operate in concert with several ATs to acetylate p53 on its C-terminal end. Phosphorylation of the N-terminal region of p53 leads to the recruitment of PCAF and p300/CBP to p53-responsive elements on the chromatin, which subsequently results in the acetylation of p53 (Gu and Roeder, 1997) . The acetylated form of p53 possesses greater stability (Gu and Roeder, 1997; Sakaguchi et al., 1998; Liu et al., 1999) . This might be explained by the fact that the acetylation sites may be the same as those targeted by the Hdm2-dependent ubiquitination pathway. Thus the proteasome would not degrade the acetylated p53 protein. Interestingly, PCAF, in addition to its AT activity, possesses an intrinsic ubiquitination activity that is critical for controlling Hdm2 expression levels. The regulatory crosstalk between PCAF and Hdm2 activities was suggested to play a central role in the subtle control of p53 activity after DNA damage (Linares et al., 2007) . In contrast to the studies suggesting a role for p53 acetylation in the stabilization of the protein, analysis of the stability of a p53 mutant in which all the previously shown six acetylatable lysine residues were mutated to arginine, indicated that ubiquitination of these lysine residues were not required for efficient p53 degradation (Feng et al., 2005) . However, p53-dependent gene regulation was impaired in the cells expressing the mutant p53 protein in a promoter-specific manner and after DNA damage. This indicates that the outcome of the post-translational modifications at the C terminus of p53 regulate its transcriptional activity after DNA damage. PCAF plays also a role in the p53-dependent cell-cycle arrest, as p53 acetylated on K320 promotes the activation of the transcription from the p21 promoter (Di Stefano et al., 2005) . While it is not clear how acetylation regulates the function of p53 (DNA-binding or co-activator recruitment activity), it seems that p53 acetylation might only modestly enhance its transcriptional activation, and perhaps only under certain specific cellular circumstances (Prives and Manley, 2001) .
It is well-established that genetic mutations that impair BRCA1 and/or BRCA2 function predispose women to early onset of breast and ovarian cancer (Lancaster et al., 1996; Turner et al., 2005; Boulton, 2006b) . BRCA1 is an E3 ubiquitin ligase that has an impact on DNA repair, transcriptional regulation, cellcycle progression and meiotic sex chromosome inactivation (Boulton, 2006a) . A biochemical approach to search for BRCA1 co-regulatory factors identified an hGCN5/TRRAP-containing complex. Genetic mutations in the C-terminal transactivation domain of BRCA1, found in breast cancer patients, caused the loss of physical interaction between BRCA1 and TRRAP and significantly reduced the co-activation of BRCA1 transactivation function by hGCN5/TRRAP (Oishi et al., 2006) . The reported transcriptional squelching between BRCA1 and oestrogen receptor a was rescued by the overexpression of TRRAP or hGCN5 (Fan et al., 1999) . The HAT activity of hGCN5 appeared to be indispensable for the function of the co-regulator complex in both BRCA1-mediated gene regulation and DNA repair (Oishi et al., 2006) . The BRCA2 gene encodes for a 3418 aa long protein, which was shown to possess a transcription activation domain (Milner et al., 1997) . Evidence implicates BRCA2 as an integral component of the homologous recombination machinery, which would also play a role in DNA repair (Sharan et al., 1997; Shamoo, 2003) . One domain of BRCA2 was reported to interact with PCAF and anti-BRCA2 immunoprecipitated samples possess a HAT activity (Fuks et al., 1998) . The interaction between PCAF and BRCA2 seems to be dependent on another co-activator, GRIP1 (Shin and Verma, 2003) . This latter recruits PCAF and p300/CBP to the chromatin through its activation domain1 (AD1), while AD2 is responsible for the BRCA2 interaction. BRCA2 associates also with the androgen receptor (AR) and by cooperating with PCAF and BRCA1 it enhances the AR-and GRIP1-mediated transactivation (Shin and Verma, 2003) . However, the role of the interactions between BRCA1 or BRCA2 and the GCN5/PCAF-containing HAT complexes in cancerogenesis is not yet well understood.
The role of HATs in virus induced tumorigenesis
Targeting of cellular HATs by viral proteins is important in the development of virus-associated diseases. Adenoviral E1A and also, though to a lesser extent, E1B cause perturbation in PCAF and p300/CBP function resulting in lower level of p53 acetylation (Chakravarti et al., 1999; Hamamori et al., 1999) . The HTLV-1 virus encoded Tax protein interacts with PCAF resulting in increased Tax transactivation, which might lead to acute T-cell leukaemia (Jiang et al., 1999; Harrod et al., 2000) . The Epstein-Barr virus encoded EBNA2 also binds to both PCAF and p300/CBP, and activates several promoters, which results in immortalization and oncogenic transformation of the cells (Wang et al., 2000) . The HIV encoded Tat becomes acetylated by PCAF and p300/CBP (Kiernan et al., 1999) leading to the transactivation of the integrated provirus (Benkirane et al., 1998) . The arginine rich region of the viral Tat protein is acetylated by PCAF, GNC5 and p300/CBP, which might compete with p53 acetylation. Tat also prevents p53 transactivation on the 14-3-3-d promoter and at the same time, due to the Tat-PCAF interaction, cells bypass the G 2 /M checkpoint and do not go to apoptosis. In HIV infected cells the level of p53 does not increase after UV irradiation as the protein does not accumulate due to the lack of stabilizing acetylation (Harrod et al., 2003) . All these phenomena together lead to an impaired tumour-suppressor function and result in the establishment of AIDS-related cancers. High-risk papilloma virus (hrHPV) infection is also known to be associated with cervical carcinoma and other cancers, and the two transforming oncogenes, E6 and E7, are both expressed in all cervical carcinomas (Snijders et al., 2006) . E7 is known to bind to tumour suppressors such as p53, p107 and p130 leading to E2F release and entering to the S phase of the cell cycle (Dyson et al., 1989) . However, the interaction between p53 and E7 alone is not enough for oncogenic transformation. Overexpressed E7 interacts with PCAF, while the L67R mutant form of E7 (zinc-finger mutation) does not, and accordingly only wild-type E7 has a negative effect on the HAT activity of PCAF. These results suggest that the oncogenic effect of E7 requires PCAF and probably its deregulated HAT function in tumour development (Avvakumov et al., 2003) .
Conclusions and future directions
In the present review, we summarized recent findings related to two homologous metazoan ATs, GCN5 and PCAF. These enzymes possess both global histone acetylation activity and locus-specific co-activator functions, together with AT activity on non-histone substrates. In vertebrates, it became clear that GCN5 or PCAF are not expressed in every cell type and even if they are coexpressed in the same cell their relative ratio can be very different. These two enzymes possess overlapping as well as specific roles, which still need to be further investigated. Moreover, when studying GCN5 and/or PCAF function, we have to keep in mind that these two proteins are subunits of at least two types of multiprotein complexes. The first having a molecular weight of 2 MDa (STAGA/TFTC/PCAF complexes) and the second of 700 kDa (ATAC complexes). At present, the existence of ATAC is demonstrated in flies and only suggested by indirect observations in vertebrate cells. These complexes have to be purified further to identify their subunits. Their roles in factor acetylation, chromatin structure maintenance and/or transcriptional activation have to be investigated. To characterize further the similarities and differences between GCN5 and PCAF function, it will be important to determine whether PCAF can also associate with smaller ATAC-type complexes. Furthermore, from the available experimental data it seems extremely important to consider that the subunit composition of the complex in which GCN5 or PCAF is incorporated has important effects on the substrate specificity of the AT (and probably other) activities of the complexes. It has to be underlined that most of the AT and co-activator assays analysing transcription factor acetylation, oncogenic activation, and virus induced disease studies have been carried out with PCAF considered as if it was a free protein in the cell. As GCN5 and PCAF does not exist as a free protein in metazoan cell nuclei (Muratoglu et al., 2003; Demeny et al., 2007 ; and our unpublished results) both enzymes seem to integrate in several different large multisubunit complexes. Thus, the involvement of PCAF and GCN5 in the abovedescribed effects has to be further investigated in the appropriate in vivo environment.
Moreover, evidence exists that epigenetic changes in the regulatory state of the chromatin may be a causal factor in determining longevity in yeast. The significance of histone acetylation by yeast GCN5 in this process has been implicated (Kim et al., 2004) . Thus, in addition to the above-described effects, it is important to understand how metazoan GCN5-and PCAF-containing complexes function in epigenetic regulation and whether they also control genome stability and aging. Nevertheless, because of the important biological roles of these complexes, which seem to harbour several enzymatic activities, it is important to dissect their diverse effects to understand the exact mechanisms by which they act. Thus, when something goes wrong in the function of these complexes resulting in cancerous transformation of the cells, we can be prepared to develop therapeutic treatments to correct the malfunctioning of these enzymes and the corresponding complexes.
